Laurent Vaur
Overview
Explore the profile of Laurent Vaur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puymirat E, Simon T, Steg P, Schiele F, Gueret P, Blanchard D, et al.
JAMA
. 2012 Aug;
308(10):998-1006.
PMID: 22928184
Context: The contemporary decline in mortality reported in patients with ST-segment elevation myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion therapy. Objective: To determine potential factors-beyond...
2.
Vaur L, Asakura T, Seino H, Kageyama M, Yohkoh N
Curr Med Res Opin
. 2008 Jul;
24(8):2373-4.
PMID: 18620630
No abstract available.
3.
Chaib A, Henegariu V, Danchin N, Gueret P, Lablanche J, Genes N, et al.
Ann Cardiol Angeiol (Paris)
. 2006 Jan;
54 Suppl 1:S24-9.
PMID: 16411648
Unlabelled: We tried to determine the prognostic impact of triple (antiplatelet agents, statins and beta-blockers) and quadruple (the same+ACE inhibitors) combination therapy at hospital discharge after acute myocardial infarction. The...
4.
Danchin N, Cambou J, Hanania G, Kadri Z, Genes N, Lablanche J, et al.
Am Heart J
. 2005 Dec;
150(6):1147-53.
PMID: 16338251
Background: Several classes of medications improve survival in patients with coronary artery disease. Whether these medications, as used in the real world, have additive efficacy remains speculative. Objectives: To assess...
5.
Danchin N, Blanchard D, Steg P, Sauval P, Hanania G, Goldstein P, et al.
Circulation
. 2004 Sep;
110(14):1909-15.
PMID: 15451803
Background: Limited data are available on the impact of prehospital thrombolysis (PHT) in the "real-world" setting. Methods And Results: Of 443 intensive care units in France, 369 (83%) prospectively collected...
6.
Danchin N, Charpentier G, Ledru F, Vaur L, Gueret P, Hanania G, et al.
Diabetes Metab Res Rev
. 2004 Sep;
21(2):143-9.
PMID: 15386810
Background: The cardiovascular effects of sulfonylureas (SU) in diabetic patients are controversial and it has been suggested that diabetic patients with acute myocardial infarction while on SU were at increased...
7.
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al.
JAMA
. 2004 Mar;
291(11):1342-9.
PMID: 15026401
Context: Blood pressure (BP) measurement in clinicians' offices with a mercury sphygmomanometer has numerous drawbacks. In contrast, the use of home BP measurement improves measurement precision and reproducibility. However, data...
8.
Vaur L, Gueret P, Lievre M, Chabaud S, Passa P
Diabetes Care
. 2003 Mar;
26(3):855-60.
PMID: 12610049
Objective: The DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study allowed investigators to analyze factors leading to the development of congestive heart failure (CHF) in type 2 diabetic...
9.
Danchin N, Angioi M, Demicheli T, Vaur L, Genes N, Ferrieres J, et al.
Am J Cardiol
. 2002 Nov;
90(10):1142-5.
PMID: 12423720
No abstract available.
10.
Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B
J Hypertens
. 2002 Mar;
20(4):779-84.
PMID: 11910316
Objective: To determine whether blood pressure control in a general practice setting is influenced by the presence of additional risk factors, and to analyse the role of antihypertensive therapy in...